We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Though the magnitude of loss due to the virus outbreak in Abbott's (ABT) Core Laboratory business is still unclear, the company's point-of-care business is anticipated to generate profit.
Gainers • Core Laboratories, Inc. (NYSE:CLB) shares moved upwards by 7.96% to $12.75 during Tuesday's pre-market session. The most recent rating by ScotiaBank, on Apr 13...
Let's see if Core Laboratories (CLB) stock is a good choice for value-oriented investors right now from multiple angles.
Let's see if Core Laboratories (CLB) stock is a good choice for value-oriented investors right now from multiple angles.

The Bottom Fishing Club: Core Labs

12:32pm, Monday, 13'th Apr 2020
Core Labs has undergone a dramatic decline in stock price during 2018-20, despite holding a profitable operating business in oilfield services. Depressed valuat

10 Biggest Price Target Changes For Monday

12:21pm, Monday, 13'th Apr 2020
Wedbush cut Starbucks Corporation (NASDAQ: SBUX) price target from $84 to $71. Starbucks closed at $73.88 on Thursday. KeyBanc raised the price target for Alibaba Group...

Core Labs Could Fly Higher

11:21am, Monday, 13'th Apr 2020
Core Labs is down over 80% over free falling oil prices. I believe much of the downside is priced in. Cost containment efforts allowed the company to deliver an
Nuveen Asset Management LLC grew its holdings in Core Laboratories (NYSE:CLB) by 8,936.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).
Core Laboratories upgraded to Outperform from Sector Perform at Scotiabank Scotiabank CLB
Core Laboratories (NYSE:CLB) was upgraded by analysts at Scotiabank to a “buy” rating in a report released on Sunday, TipRanks reports. The brokerage currently has a $13.00 price objective on the
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE